tiprankstipranks
Trending News
More News >
InDex Pharmaceuticals Holding AB (DE:1NP1)
FRANKFURT:1NP1
Germany Market

InDex Pharmaceuticals Holding AB (1NP1) Financial Statements

Compare
3 Followers

InDex Pharmaceuticals Holding AB Financial Overview

InDex Pharmaceuticals Holding AB's market cap is currently €317.70M. The company's EPS TTM is €-0.295101635; its P/E ratio is 0.30; InDex Pharmaceuticals Holding AB is scheduled to report earnings on April 16, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenuekr 100.00Kkr 97.50Mkr 0.00kr 0.00kr 35.00K
Gross Profitkr 100.00Kkr 93.35Mkr -1.07Mkr -1.25Mkr -57.73M
Operating Incomekr -275.00Mkr -107.37Mkr -151.11Mkr -115.63Mkr -57.73M
EBITDAkr -225.90Mkr -93.82Mkr -99.15Mkr -101.66Mkr -56.11M
Net Incomekr -228.00Mkr -95.27Mkr -100.33Mkr -103.04Mkr -57.42M
Balance Sheet
Cash & Short-Term Investmentskr 865.10Mkr 294.27Mkr 344.93Mkr 428.45Mkr 53.83M
Total Assetskr 4.22Bkr 299.39Mkr 351.34Mkr 445.20Mkr 61.18M
Total Debtkr 800.00Kkr 2.30Mkr 3.25Mkr 1.28Mkr 2.34M
Net Debtkr -864.30Mkr -291.97Mkr -341.68Mkr -427.17Mkr -51.49M
Total Liabilitieskr 25.30Mkr 60.50Mkr 17.38Mkr 11.16Mkr 11.86M
Stockholders' Equitykr 4.20Bkr 238.88Mkr 333.96Mkr 434.04Mkr 49.33M
Cash Flow
Free Cash Flowkr -17.00Mkr -37.98Mkr -129.44Mkr -124.06Mkr -71.56M
Operating Cash Flowkr -17.00Mkr -37.98Mkr -129.44Mkr -124.06Mkr -70.65M
Investing Cash Flowkr -19.80Mkr -625.20Mkr 0.00kr 0.00kr -909.00K
Financing Cash Flowkr 571.90Mkr 634.70Mkr -818.00Kkr 486.39Mkr -1.40M
Currency in SEK

InDex Pharmaceuticals Holding AB Earnings and Revenue History

InDex Pharmaceuticals Holding AB Debt to Assets

InDex Pharmaceuticals Holding AB Cash Flow

InDex Pharmaceuticals Holding AB Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis